|
1. Randy A. Taplitz, Erin B. Kennedy, et al. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. Journal of Clinical Oncology. 2018 36:30, 3043-3054. https://ascopubs.org/doi/10.1200/JCO.18.00374#con1, https://ascopubs.org/doi/10.1200/JCO.18.00374#con2, https://ascopubs.org/doi/10.1200/JCO.18.00374#con3
2. Dadwal SS, Hohl TM, Fisher CE, et al. American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients. Transplant Cell Ther. 2021 Mar;27(3):201-211.
3. Vallejo C, Jarque I, Fortun J, et al. IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients. J Fungi (Basel). 2023 May 30;9(6):628.
4. Azanza JR, Mensa J, Barberán J, et al. Recommendations on the use of azole antifungals in hematology-oncology patients. Rev Esp Quimioter. 2023 Jun;36(3):236-258.
5. Vázquez López L, Villaescusa de la Rosa T, de la Cámara R, et al. Posicionamiento y actitudes de manejo sobre la profilaxis antifúngica en el paciente hematológico (proyecto PROMIC). Rev Esp Quimioter 2017;30(3): 213-223.
6. Vallejo C, Vázquez L, Cabrera Martín JR, et al. Treatment of invasive fungal infections in high-risk haematological patients: what have we learnt in the past 10 years? Rev Esp Quimioter. 2013 Dec;26(4):378-86.
7. National Comprehensive Cancer Network. Prevention and treatment of Cancer-Related Infections (Version 2.2023). https://www.nccn.org/professionals/physician_gls/pdf/infections.pdf. Acceso 10 Marzo, 2024.
8. Moreno F, Gomez B. Antibiotic Management of Patients with Hematologic Malignancies: From Prophylaxis to Unusual Infections. Curr Oncol Rep. 2022 Jul;24(7):835-842.
|
